PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 2026JAMA Network Open0 citationsOpen Access

Economic Evaluation of Thymectomy for Nonthymomatous Myasthenia Gravis Treatment

Economic Evaluation of Thymectomy for the Treatment of Nonthymomatous Myasthenia Gravis

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJenny LordMWMatthew WaltonPMPeter J. Murphy

Discussion

Loading...

Member takes

Overview

Economic evaluation shows thymectomy as a cost-effective treatment for nonthymomatous myasthenia gravis, suggesting it should be widely recommended.

Key Points

  • Evaluate the economic impact of thymectomy compared to traditional treatments for nonthymomatous myasthenia gravis.
  • Conducted a cost-effectiveness analysis in the UK
  • Compared thymectomy costs to prednisolone alone
  • Utilized data from randomized clinical trials
  • Thymectomy demonstrated high cost-effectiveness
  • Thymectomy is likely to save costs compared to prednisolone alone
  • Support for clinical guidelines recommending thymectomy for eligible patients

Cite This Study

Lord et al. (2026) studied this question.

synapsesocial.com/papers/69df2c77e4eeef8a2a6b19ffhttps://doi.org/10.1001/jamanetworkopen.2026.6612
View Full Paper
Ask AI
Bookmark
Share